
GLP-1 and obesity medicine news.
| Platform | Pricing | Freemium | Publishes | Daily | |
|---|---|---|---|---|---|
| Issues | 446 | Founded | a year ago | Last Issue | 8 days ago |
| Active | |||||

These are fun videos… The videos where we get to introduce you to new molecules that no one else on the web is talking about. See you live at 12pm Eastern! Click to watch below and make sure to subscribe, and hit the thumbs up while you’re...
There are stories that make headlines, and then there are stories that quietly shape the future before most people even realize they’re watching history unfold. I believe the fight over retatrutide’s biologic status is one of those stories....
When the SAFE Drugs Act was first introduced, we viewed it as uniquely threatening to the On The Pen community. While much of the initial conversation surrounding this bill centered on pharmacy regulation and FDA authority, our concern was...
For nearly two years, one of the biggest unanswered questions surrounding retatrutide wasn’t how much weight people would lose. We already had a pretty good idea of that from the Phase 2 data. The bigger question was what would happen once...
This may be one of the most important obesity papers published all year.
This may be one of the most important obesity papers published all year. Not because it introduces a new drug, but because it challenges one of the biggest assumption...
Subscribers, engagement, traffic and sponsorship for ON THE PEN.
| Subscribers | Engagement | 80 | Monthly Web Visits | ||
|---|---|---|---|---|---|
| Accepts Sponsors | Estimated Cost per Ad | ||||
Where ON THE PEN ranks on Google, and how much search traffic it brings in.
| Ranked Keywords | 182 | Monthly Search Traffic | Top Keywords |
|---|
How this newsletter ranks in the official Substack charts.
| #216 | |
| #134 |
The writers behind this newsletter.
On The Pen is the leading GLP-1 news podcast and platform covering obesity medicine, FDA actions, drug shortages, access policy, and the business of NuSH therapies. On The Pen is a top Substack best-seller.
Building a resource for useful, actionable, and grounded in real-life lifestyle health upgrades. Guest writer for https://onthepen.substack.com/
You can find recent issues that have been published by ON THE PEN on Reletter by scrolling up to where it says Latest Issues. Tap on the link for any of the most recent emails or hit More Issues to see older ones.
To see how many people subscribe to ON THE PEN, simply upgrade your Reletter account. We provide readership numbers and lots of other stats for this newsletter so you can decide if it's worth reaching out to.
Newsletter advertising can be extremely effective when it's done right. Before you pitch ON THE PEN as a potential sponsor or partner, make sure that you've done your research and checked its newsletter stats with Reletter.
Then, personalize one of our winning pitching templates and send it to the right person using the contact info provided.
Newsletter ad rates (or CPM) vary depending on many factors, including industry, number of subscribers, open rate, ad placement and more.
To find out how much an ad will cost, contact ON THE PEN using the contact information provided and ask for a copy of their media kit.
Scroll up to where it says Related Newsletters to see other publications like ON THE PEN. You can also search our email newsletter directory to discover other newsletters that cover the topics you're interested in.
Reletter provides this newsletter's website URL above, where you will often find their contact information. We also provide links to associated social media accounts and pitching templates so you can reach out fast.